[HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
The frequency of 36 HLA-SD antigens were investigated in 42 patients with cervix cancer, 36 female patients with recurrent Herpes genitalis and 450 healthy controls. The only significant difference between the 3 groups was an increase in the frequency of BW 15 in the cervix cancer patients. The patients with recurrent Herpes genitalis--who were sero-epidemiologically determined to have a higher risk of developing a cervix carcinoma-showed no significant difference in their HLA-SD antigen frequencies in comparison with the controls and the cervix carcinoma patients.
D000914:Antibodies, Viral / Q000032:analysis; D002908:Chronic Disease; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005831:Genital Diseases, Female / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis*; D006566:Herpesviridae Infections / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000032:analysis*; D006801:Humans; D012008:Recurrence; D002583:Uterine Cervical Neoplasms / Q000276:immunology*
D000914:Antibodies, Viral; D006680:HLA Antigens; D006649:Histocompatibility Antigens
HLA-SD-Antigene bei Zervix-Karzinom und chronisch rezidivierendem Herpes genitalis (Mitteilung)